Astera Labs (NASDAQ:ALAB) Stock Price Down 9.2% - Should You Sell?

Key Points

• Astera Labs shares fell 9.2% to $347.05 on elevated trading volume, bringing the stock close to the analyst consensus price target of $348.33.
• Analyst sentiment remains positive but mixed, with 12 Buy ratings and nine Holds producing a “Moderate Buy” consensus; price targets range from $275 to $450.
• The company reported strong quarterly results, including $0.80 EPS and $392.4 million in revenue, up 104.5% year over year. However, its high valuation—about 172 times earnings—and $122.6 million in insider stock sales over the past quarter may concern investors.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares dropped 9.2% on Thursday. The company traded as low as $342.54 and last traded at $347.05. 6,413,945 shares traded hands during mid-day trading, an increase of 23% from the average session volume of 5,196,890 shares. The stock had previously closed at $382.25.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. Barclays boosted their target price on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research report on Monday, July 20th. Jefferies Financial Group increased their target price on Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Northland Securities upgraded Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 price target on the stock in a research report on Monday, August 17th. TD Cowen decreased their price target on Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a research note on Wednesday, August 5th. Finally, Susquehanna boosted their price objective on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a research report on Friday, July 31st. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $348.33.

Astera Labs Price Performance

The business has a 50 day moving average of $315.87 and a 200 day moving average of $288.40. The company has a market cap of $60.21 billion, a PE ratio of 171.81 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the previous year, the firm earned $0.44 EPS. The company's quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Buying and Selling

In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the firm's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director directly owned 253,863 shares in the company, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 396,059 shares of company stock valued at $122,605,660 over the last quarter. 10.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cooper Financial Group bought a new position in Astera Labs in the third quarter worth $203,000. MRA Advisory Group boosted its holdings in shares of Astera Labs by 19.6% during the 3rd quarter. MRA Advisory Group now owns 4,299 shares of the company's stock valued at $1,530,000 after buying an additional 705 shares in the last quarter. QRG Capital Management Inc. boosted its holdings in shares of Astera Labs by 8.7% during the 2nd quarter. QRG Capital Management Inc. now owns 4,775 shares of the company's stock valued at $2,306,000 after buying an additional 381 shares in the last quarter. Silicon Valley Capital Partners grew its position in shares of Astera Labs by 99.0% in the 2nd quarter. Silicon Valley Capital Partners now owns 1,990 shares of the company's stock worth $961,000 after buying an additional 990 shares during the period. Finally, Twin Peaks Capital Ltd purchased a new stake in shares of Astera Labs in the 2nd quarter worth about $4,830,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.